Brief: ISR Immune System Regulation Holding Signs Agreement With Oncovir
Dec 2 (Reuters) - ISR Immune System Regulation Holding AB
(publ) ISR.ST :
* SIGNS AGREEMENT WITH ONCOVIR
* CONTRACT FOR RIGHTS TO USE THEIR HILTONOL IN SARS-COV-2
VACCINE
Source text for Eikon: ID:nWkrbzFJMY
Further company coverage: ISR.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on ISR Immune System Regulation Holding AB (publ)
See all newsBrief: ISR Holding Shares To Be Delisted From Nasdaq First North Growth Market
Brief: Nasdaq Stockholm Hands Over Investigation Of ISR Holding To Disciplinary Committee
Brief: ISR Immune System Regulation Holding Receives Notice Of Objection From Nasdaq
Brief: ISR FY 2022 Oper Loss Widens To SEK 205.1 Mln
Brief: ISR Signs Development Agreements With Catalent